English version
Sitemap | LMU | LMU-Portal


Forschung > Medizinische Mikrobiologie und Krankenhaushygiene > AG Wieser > Publikationen > 

Publikationen

 

 First/last authorships Wieser in bold;
*: contributed equally

2017:

First insights in the variability of Borrelia recurrentis genomes. Marosevic D, Margos G, Wallich R, Wieser A, Sing A, Fingerle V., PLoS Negl Trop Dis. 2017 Sep 13;11(9):e0005865. IMPACT: 7,64 (2015)

The small liver fluke (Dicrocoelium dendriticum): an unusual clinical finding in chronic urticarial, Blatner C, Oppel E M, Wieser A, Herzinger T, Ruëff F, Allergo Journal International, DOI: 10.1007/s40629-017-0021-3 IMPACT: 1 (2015)

"Neue mikrobiologische Techniken"
S. Schubert, A. Wieser, G. Bonkat
Der Urologe, DOI 10.1007/s00120-017-0395-3

First report on bla NDM-1-producing Acinetobacter baumannii in three clinical isolates from Ethiopia; Pritsch M*, Zeynudin A*, Messerer M, Baumer S, Liegl G, Schubert S, Löscher T, Hoelscher M, Belachew T, Rachow A, Wieser A. BMC Infect Dis. 2017 Mar 1;17 IMPACT: 2,82 (2015)

Analysis of the Virulence of Uropathogenic Escherichia coli Strain CFT073 in the Murine Urinary Tract. Waldhuber, A., Puthia, M., Wieser, A., Svanborg, C. and Miethke, T. (2017). Bio-protocol 7(3): e2129

2016:

Aktuelle Situation des Läuserückfallfiebers unter besonderer Berücksichtigung von Asylsuchenden. Fingerle F, Ackermann N, Belting A, Hoch M, Liebl B, Margos G, Pürner F, Schönberger K, Wieser A, Sing A. Hyg Med. 2016; 41(11)

Strain-specific impact of the high-pathogenicity island on virulence in extra-intestinal pathogenic Escherichia coli; Smati M, Magistro G, Adiba S, Wieser A, Picard B, Schubert S, Denamur E. Int J Med Microbiol. 2016 Nov 22; IMPACT: 3,898 (2015)

Drug resistance and population structure of M. tuberculosis isolates from prisons and communities in Ethiopia; Ali S, Beckert P,Haileamlak A, Wieser A, Pritsch M, Heinrich N, Loscher T, Hoelscher M, Niemann S, Rachow A. BMC Infectious Dis. 2016 Nov 21;16(1):687. IMPACT: 2,17 (2015)

Similar trends of susceptibility in Anopheles arabiensis and Anopheles pharoensis to Plasmodium vivax infection in Ethiopia; Abduselam N, Zeynudin A, Berens-Riha N, Seyoum D, Pritsch M, Tibebu H, Eba K, Hoelscher M, Wieser A*, Yewhalaw D.* (*last authors contributed equally, correspondence Wieser A.) Parasites and Vectors, 2016 Oct 18;9(1):552. IMPACT: 3,32 (2014)

Adjunctive dexamethasone therapy in unconfirmed bacterial meningitis in resource limited settings: is it a risk worth taking? Gudina E K, Tesfaye M, Adane A, Kinfe L, Shibiru T, Wieser A, Pfister H-W, Klein M. BMC Neurology 2016 Aug 26;16(1):153. IMPACT: 1,961 (2015)       

Louse-Borne-Relapsing Fever in refugees from the Horn of Africa; a case series of 25 patients; Seilmaier M, Guggemos W, Wieser A, Fingerle V, Balzer L, Fenzl T, Hoch M, von Both U, Schmidt HU, Wendtner CM, Strobel E. DMW (2016) IMPACT: 0,503 (2015)      

Relapsing Fever: an almost forgotten disease in focus again; Wieser A, Löscher T, Schunk M, Seilmaier M, Balzer L, Margos G, von Both U, Schulzki T, Kopf S, Hoch M, Sing A, Fingerle V; Deutsche Medizinische Wochenschrift (DMW), 2016 Jul; 141(14). IMPACT: 0,542 (2014)

The uropathogenic Escherichia coli strain CFT073 disrupts the inflammasome A, Cirl C, Dürr S, Neumann-Pfeifer S, Albrecht S, Römmler F, Müller T, Zheng Y, Schubert S, Groß O, Svanborg C, Miethke T. J CLIN INVEST 2016 Jul 1;126(7):2425-36 IMPACT: 13,22 (2014)

 “Candidatus Borrelia kalaharica” detected from a febrile traveller returning to Germany from vacation in Southern Africa; Fingerle V*, Pritsch M*, Wächtler M, Margos G, Ruske S, Jung J, Löscher T, Wendtner C, Wieser A (*first authors contributed equally) PLOS Negl Trop Dis. 2016 Mar 31;10(3):e0004559. IMPACT: 4,45 (2014)

Photodynamic Inactivation of Actinomyces naeslundii in Comparison with Chlorhexidine and Polihexanide – a new approach for antiseptic treatment of MRONJ? Hafner S, Storz E, Wieser A; Journal of Oral and Maxillofacial Surgery (JOMS), 2016 Mar;74(3):516-22; IMPACT: 1,43 (2014)

“Comparison of Intranasal Outer Membrane Vesicles with Cholera Toxin and Injected MF59C.1 as Adjuvants for Malaria Transmission Blocking Antigens AnAPN1 and Pfs48/45; Pritsch M, Ben-Khaled N, Chaloupka M, Kobold S, Berens-Riha N, Peter A, Liegl G, Schubert S, Hoelscher M, Loscher T, Wieser A. Journal of Immunology Research 2016; 2016:3576028. IMPACT: 2,93 (2014)

2015:

Louse-borne relapsing fever (Borrelia recurrentis) diagnosed in 15 refugees from northeast Africa: epidemiology and preventive control measures, Bavaria, Germany, July to October 2015; Hoch M, Wieser A, Löscher T, Margos G, Pürner F, Zühl J, Seilmaier M, Balzer L, Guggemos W, Rack-Hoch A, von Both U, Hauptvogel K, Schönberger K, Hautmann W, Sing A, Fingerle V. Eurosurveillance (2015), Volume 20, Issue 42, 22 October 2015. IMPACT: 5,7 (2014)

Primary skin melioidosis in a returning traveller. Huber K, Thoma B, Löscher T, Wieser A. Infection. 2015 Aug;43(4):507-8. IMPACT: 2,86

Label-Free In-Situ Discrimination of Live and Dead Bacteria by Surface-Enhanced Raman Scattering; Zhou H, Yang D, Ivleva NP, Mircescu NE, Schubert S, Niessner R, Wieser A*, Haisch C*; (*contributed equally); Analytical Chemistry 2015, Jul; 7; 87(13):6553-61 IMPACT: 5,83 (2014)

Prevalence of pulmonary tuberculosis among prison inmates in Ethiopia, a cross-sectional study; Ali S, Haileamlak A, Wieser A, Pritsch M, Heinrich N, Loescher T, Hoelscher M, Rachow A. PLoS ONE (2015). Volume 10, Issue 12 IMPACT: 3,23 (2014)

Surface-enhanced Raman scattering detection of bacteria on microarrays at single cell levels using silver nanoparticles; Zhou H, Yang D, Mircescu NE, Ivleva NP, Schwarzmeier K, Wieser A, Schubert S, Niessner R, Haisch C. Microchimica Acta. (2015) IMPACT: 3,74

Molecular markers of anti-malarial drug resistance in southwest Ethiopia over time: regional surveillance from 2006 to 2013; Heuchert A, Abduselam N, Zeynudin A, Eshetu T, Löscher T, Wieser A, Pritsch M, Berens-Riha N; Malaria J. (2015) 14:208. IMPACT: 3,49

Efficacy and safety of triple combination therapy with artesunate-amodiaquine-methylene blue for falciparum malaria in children: a randomized controlled trial in burkina faso. Coulibaly B, Pritsch M, Bountogo M, Meissner PE, Nebié E, Klose C, Kieser M, Berens-Riha N, Wieser A, Sirima SB, Breitkreutz J, Schirmer RH, Sié A, Mockenhaupt FP, Drakeley C, Bousema T, Müller O. J Infect Dis. 2015 Mar 1; 211(5):689-97. IMPACT: 5,78

2014:

Efficient quantification and characterization of bacterial outer membrane derived nano-particles with flow cytometric analysis. Wieser A, Storz E, Liegl G, Peter A, Pritsch M, Shock J, Wai SN, Schubert S. Int J Med Microbiol. 2014 Nov; 304(8):1032-7. IMPACT: 3,42

Bacteriophage-based latex agglutination test for rapid identification of Staphylococcus aureus. Idelevich EA, Walther T, Molinaro S, Li X, Xia G, Wieser A, Peters G, Peschel A, Becker K. J Clin Microbiol. 2014 Sep; 52(9):3394-8. Epub 2014 Jul 16. IMPACT: 4,23

Corticosteroid-induced meningococcal meningitis in a patient with chronic meningococcemia. Wenzel M, Jakob L, Wieser A, Schauber J, Dimitriadis K, Schubert S, Pfister HW. JAMA Dermatol. 2014 Jul; 150(7):752-5. IMPACT: 4,3

Rapid detection of antibiotic resistance based on mass spectrometry and stable isotopes. Jung JS, Eberl T, Sparbier K, Lange C, Kostrzewa M, Schubert S*, Wieser A*; (*contributed equally); Eur J Clin Microbiol Infect Dis. 2014 Jun; 33(6):949-55. IMPACT: 2,54

Towards a receptor-free immobilization and SERS detection of urinary tract infections causative pathogens. Mircescu NE, Zhou H, Leopold N, Chiş V, Ivleva NP, Niessner R, Wieser A, Haisch C. Anal Bioanal Chem. 2014 May; 406(13):3051-8. IMPACT: 3,58X

TcpC protein from E. coli Nissle improves epithelial barrier function involving PKCζ and ERK1/2 signaling in HT-29/B6 cells. Hering NA, Richter JF, Fromm A, Wieser A, Hartmann S, Günzel D, Bücker R, Fromm M, Schulzke JD, Troeger H. Mucosal Immunol. 2014 Mar; 7(2):369-78. IMPACT: 7,54

2013:

Molecular analysis of a novel Toll/interleukin-1 receptor (TIR)-domain containing virulence protein of Y. pseudotuberculosis among Far East scarlet-like fever serotype I strains. Nörenberg D, Wieser A, Magistro G, Hoffmann C, Meyer C, Messerer M, Schubert S. Int J Med Microbiol. 2013 Dec; 303(8):583-94. IMPACT: 3,42

Evaluation of Plasmodium falciparum gametocyte detection in different patient material. Kast K, Berens-Riha N, Zeynudin A, Abduselam N, Eshetu T, Löscher T, Wieser A, Shock J, Pritsch M. Malar J. 2013 Dec 4; 12:438. IMPACT: 3,49

MALDI biotyper-based rapid resistance detection by stable-isotope labeling. Sparbier K, Lange C, Jung J, Wieser A, Schubert S, Kostrzewa M. J Clin Microbiol. 2013 Nov; 51(11):3741-8. IMPACT: 4,23

Triple worm infestation in an HIV-infected patient. Sammet S, Wieser A, Müller S, Huber M, Schubert S, Seybold U. Infection. 2013 Oct; 41(5):1053-4. IMPACT: 2,86

2012:

Open-label trial with artemether-lumefantrine against uncomplicated Plasmodium falciparum malaria three years after its broad introduction in Jimma Zone, Ethiopia. Eshetu T, Abdo N, Bedru KH, Fekadu S, Wieser A, Pritsch M, Löscher T, Berens-Riha N. Malar J. 2012 Jul 23; 11:240. IMPACT: 3,40

Salmonella transiently reside in luminal neutrophils in the inflamed gut. Loetscher Y, Wieser A, Lengefeld J, Kaiser P, Schubert S, Heikenwalder M, Hardt WD, Stecher B. PLoS One. 2012; 7(4):e34812. IMPACT: 3,73

Stability of gametocyte-specific Pfs25-mRNA in dried blood spots on filter paper subjected to different storage conditions. Pritsch M*, Wieser A*, Soederstroem V, Poluda D, Eshetu T, Hoelscher M, Schubert S, Shock J, Loescher T, Berens-Riha N.(*contributed equally); Malar J. 2012 Apr 30; 11:138. IMPACT: 3,40

A Novel Method for the Preparation of a Strain-Adapted Vaccine; Schubert S. 50%, Wieser A. 50% LMU-Patentanmeldung PCT/EP2013/057216 eingereicht am 5. April 2012

First multi-epitope subunit vaccine against extraintestinal pathogenic Escherichia coli delivered by a bacterial type-3 secretion system (T3SS). Wieser A, Magistro G, Nörenberg D, Hoffmann C, Schubert S. Int J Med Microbiol. 2012 Jan; 302(1):10-8. IMPACT: 4,54

2011:

Novel, improved sample preparation for rapid, direct identification from positive blood cultures using matrix-assisted laser desorption/ionization time-of-flight (MALDI-TOF) mass spectrometry. Schubert S, Weinert K, Wagner C, Gunzl B, Wieser A, Maier T, Kostrzewa M. J Mol Diagn. 2011 Nov; 13(6):701-6. IMPACT: 3,58

Intra- und extrazelluläre Biofilme uropathogener E. coli - Bedeutung für die Pathogenese des Harnwegsinfekts; Wieser A, Schubert S. Chemother J 2011; 20:181–5.

Einsatz der matrix assisted laser desorption/ionisation-time of flight Massenspektrometrie (MALDI-TOF MS) in der mikrobiologischen Routinediagnostik; Schubert S, Wieser A. J Lab Med 2011; 35(4):195

A novel ex vivo set-up for dynamic long-term characterization of processes on mucosal interfaces by confocal imaging and simultaneous cytokine measurements. Wieser A*, Guggenberger C*, Pritsch M, Heesemann J, Schubert S. (*contributed equally); Cell Microbiol. 2011 May; 13(5):742-51. IMPACT: 5,46

MALDI-TOF MS in microbiological diagnostics-identification of microorganisms and beyond (mini review). Wieser A, Schneider L, Jung J, Schubert S. Appl Microbiol Biotechnol. 2012 Feb; 93(3):965-74. Epub 2011 Dec 25.

2010:

MALDI-TOF MS in der mikrobiologischen Diagnostik; Wieser A, Schubert S. Biospektrum 07.10 (760-762), 16. Jahrgang

Prevalence and phylogenetic history of the TcpC virulence determinant in Escherichia coli. Schubert S, Nörenberg D, Clermont O, Magistro G, Wieser A, Romann E, Hoffmann C, Weinert K, Denamur E. Int J Med Microbiol. 2010 Nov; 300(7):429-34. IMPACT: 2,40

A multiepitope subunit vaccine conveys protection against extraintestinal pathogenic Escherichia coli in mice. Wieser A, Romann E, Magistro G, Hoffmann C, Nörenberg D, Weinert K, Schubert S. Infect Immun. 2010 Aug; 78(8):3432-42. IMPACT: 4,10

2009:

Role of intraspecies recombination in the spread of pathogenicity islands within the Escherichia coli species. Schubert S, Darlu P, Clermont O, Wieser A, Magistro G, Hoffmann C, Weinert K, Tenaillon O, Matic I, Denamur E.  PLoS Pathog. 2009 Jan; 5(1):e1000257. IMPACT: 8,98

 2008:

Subversion of Toll-like receptor signaling by a unique family of bacterial Toll/interleukin-1 receptor domain-containing proteins. Cirl C, Wieser A, Yadav M, Duerr S, Schubert S, Fischer H, Stappert D, Wantia N, Rodriguez N, Wagner H, Svanborg C, Miethke T. Nat Med. 2008 Apr; 14(4):399-406. IMPACT: 27,55